Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2025 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options

CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
January 10, 2025 08:00 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025

CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
December 17, 2024 08:00 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
November 12, 2024 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 05, 2024 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics to Participate in Upcoming Investor Conferences

CARGO Therapeutics to Participate in Upcoming Investor Conferences
November 05, 2024 09:23 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity

CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma
August 12, 2024 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
July 18, 2024 07:21 ET | Source: Research and Markets

CD19/CD20 Bi-Specific CAR-T Pipeline Research Report 2024: In-depth Analysis of the Pipeline Assets, Therapeutic Assessment and Comparative Analysis

Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "CD19/CD20 Bi-Specific CAR-T - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.CD19/CD20 Bi-Specific CAR-T...
July 10, 2024 08:00 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
June 14, 2024 06:23 ET | Source: Research and Markets

CAR-T Therapy Pipeline Landscape Report, 2024 - Features Insights on Emerging Drugs CT053, Descartes-08, ALLO-501A, CTX110, and IMPT 314

Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "CAR-T Therapy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This report provides in-depth insights into the...

Next Page keyboard_arrow_right